Trinucleotide (CAG) repeat length is positively correlated with the degree of DNA fragmentation in Huntington's disease striatum (Q45296389)

11 December 2017

Trinucleotide (CAG) repeat length is positively correlated with the degree of DNA fragmentation in Huntington's disease striatum (English)

1 reference

11 December 2017

0 references

1 reference

0 references

4

Love DR

1 reference

11 December 2017

Butterworth NJ

1

1 reference

11 December 2017

Williams L

2

1 reference

11 December 2017

Bullock JY

3

1 reference

11 December 2017

Faull RL

5

1 reference

11 December 2017

Dragunow M

6

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 November 1998

1 reference

11 December 2017

1 reference

11 December 2017

87

1 reference

11 December 2017

1

1 reference

11 December 2017

49-53

1 reference

The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease

11 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900129-8

7 January 2021

Neuronal types in the striatum of man

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900129-8

7 January 2021

Trinucleotide repeat length and clinical progression in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900129-8

7 January 2021

A potential role for apoptosis in neurodegeneration and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900129-8

7 January 2021

The role of inducible transcription factors in apoptotic nerve cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900129-8

7 January 2021

Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900129-8

7 January 2021

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900129-8

7 January 2021

Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900129-8

7 January 2021

Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900129-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900129-8

1 reference

7 January 2021

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900129-8

7 January 2021

Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900129-8

7 January 2021

Neurobiology of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900129-8

7 January 2021

Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900129-8

7 January 2021

DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900129-8

7 January 2021

Neuropathological classification of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900129-8

7 January 2021

Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2898%2900129-8

7 January 2021

10.1016/S0306-4522(98)00129-8

Identifiers

DOI

1 reference

11 December 2017

1 reference